A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
about
Implantable defibrillators versus medical therapy for cardiac channelopathiesImplantable defibrillators versus medical therapy for cardiac channelopathiesService organisation for the secondary prevention of ischaemic heart disease in primary careService organisation for the secondary prevention of ischaemic heart diseaseThe current status of primary prevention in coronary heart diseaseDesign of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus ComprehenThe Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease--results after one yearPrognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population studySecondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issuesImproving secondary prevention in coronary bypass patients: closing the audit loopNurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trialCluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary careMissing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease.Development and evaluation of complex interventions in health services research: case study of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group.Fatality outside hospital from acute coronary events in three British health districts, 1994-5. United Kingdom Heart Attack Study Collaborative Group.Exercise-based rehabilitation for coronary heart disease.Cholesterol risk management: a systematic examination of the gap from evidence to practice.Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.Undertreatment of hyperlipidemia in the secondary prevention of coronary artery diseaseContribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994Cardiac rehabilitation: socially deprived patients are less likely to attend but patients ineligible for thrombolysis are less likely to be invitedManagement of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contractSecondary prevention of hypercholesterolaemia: results of an audit conducted in South Wales.Improvements in total mortality and lipid levels after acute myocardial infarction in an English health district (1995-1999).Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study.Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE).Secondary prevention in 24, 431 patients with coronary heart disease: survey in primary care.Risk Factors of Coronary Artery Disease in Secondary Prevention--Results from the AtheroGene--Study.Determinants of the blood pressure response to the first dose of ACE inhibitor in mild to moderate congestive heart failure.Australian nurses in general practice based heart failure management: implications for innovative collaborative practice.General practitioners' adherence with clinical reminders for secondary prevention of dyslipidemia.Ten year audit of secondary prevention in coronary bypass patients.Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records.Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group.Secondary prevention in coronary heart disease: baseline survey of provision in general practice.Time trend analysis and variations in prescribing lipid lowering drugs in general practiceAutoimmune channelopathies as a novel mechanism in cardiac arrhythmias.Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.Preparing for change in the secondary prevention of coronary heart disease: a qualitative evaluation of cardiac rehabilitation within a region of Scotland.
P2860
Q24186596-A925903F-9B3D-4990-B4CD-24E532185C9AQ24194254-51752A71-CA49-448B-8A52-AA8F3D017D4AQ24236791-BD3F16D7-AF2E-4B94-816F-182DFA9BE761Q24243104-9F4F8A89-6292-4DEE-BAD2-0F64ABAC1D04Q24793532-12548AF2-14EE-4009-B16F-C4BB30F49B0EQ24804409-9C98E184-9201-4BDB-AE19-56024B823B53Q28168784-71E04422-E0E7-487E-A8E9-6AAC24496B72Q28193179-2F163772-F198-4302-BA24-0C717F4F82AFQ28194446-3B620921-EEBC-4F6A-BAB1-54960EF4A4B5Q28210679-F78DA220-544A-444E-81BC-BD5E2C47C5E1Q28346462-7844E0ED-5839-4B7A-8B4E-9BA614BD9396Q28366114-934BA681-5560-4F9B-924A-5A37C8C69299Q30806056-6ED5D278-0BD3-4D0C-A2F7-D3DC3A561313Q33540492-15A2A4DA-C572-4D7C-8596-FA4677900B05Q33775173-070ADAD8-01CC-448F-8360-0DFA66E4BED2Q34062297-8A105971-F6D4-4377-9DFA-AED888D52FDFQ34303364-08B16FE1-4501-42A3-B6AD-9F891E54C229Q34742537-720DC4DB-747B-4E9B-8D71-17AE3D4C8F90Q34751162-77215629-C454-4273-832B-45CAFEE7585AQ35371795-61FCCBE2-4D1B-4C0C-A4F7-14F6D8B0BCF7Q35373548-697E75A7-EB49-4C3B-A182-F43B44C27DD7Q35521982-870E9A92-5E57-4BF4-8B92-E87A62C614EFQ35566901-BD89E2DE-FA6E-4595-AF78-FCECD72CB316Q35579917-A5F52555-B22F-41D8-81BE-478C52E56A64Q35580593-9EEC34B1-E95F-4B6A-BD00-0B7F8A3FB6E1Q35581017-8405EB9C-472B-4EF7-8C12-242AC17EDA83Q35583786-51A3A73C-9F8A-4A0B-A165-2925ACAB6F35Q35593244-AD75361F-C360-4AD5-9CD8-2F9FD693B1CCQ35686023-B47DF831-2E7B-42A1-A51A-84E471A26F16Q35802493-E935CD9F-23E7-4E64-A48A-CE815C1B111FQ35826830-62CF08AD-0806-43FB-A746-D561B2D9AB4FQ37128665-20D4E053-5968-4A76-8593-2D86AB0171B5Q37342318-4B56A21B-958C-400B-B9F6-5704CC0EFC3DQ37353956-130D114D-22E1-4514-A67E-43FC12C7E64CQ37423244-B8863FDA-E482-4BD5-A32A-FA3A2F013F61Q38644473-23EB8A74-A4AF-4386-B001-E214DCE9E5ADQ38646587-A481E747-7C3D-4163-BA7E-B496B7F5CEF4Q39282353-A18ECF64-A656-475E-B36E-7B6009AA6F55Q40628124-99BE34FA-EEFF-4BEB-887F-0F6B9504E7FDQ40636646-56DD8478-6261-435E-A2E9-CDA55641710C
P2860
A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A British Cardiac Society surv ...... ntervention to Reduce Events).
@en
type
label
A British Cardiac Society surv ...... ntervention to Reduce Events).
@en
prefLabel
A British Cardiac Society surv ...... ntervention to Reduce Events).
@en
P2093
P2860
P356
P1433
P1476
A British Cardiac Society surv ...... ntervention to Reduce Events).
@en
P2093
B Schofield
H L Hobson
N R McLennan
T C Clayton
T J Bowker
P2860
P304
P356
10.1136/HRT.75.4.334
P407
P577
1996-04-01T00:00:00Z